creatine has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, CB | 1 |
Kim, SY | 1 |
Lee, SH | 1 |
Jahng, GH | 1 |
Kim, HY | 1 |
Choe, BY | 1 |
Ryu, KN | 1 |
Yang, DM | 1 |
Yim, SV | 1 |
Choi, WS | 1 |
Klivenyi, P | 2 |
Calingasan, NY | 1 |
Starkov, A | 1 |
Stavrovskaya, IG | 1 |
Kristal, BS | 1 |
Yang, L | 2 |
Wieringa, B | 1 |
Beal, MF | 2 |
Matthews, RT | 1 |
Ferrante, RJ | 1 |
Klein, AM | 1 |
Mueller, G | 1 |
Kaddurah-Daouk, R | 1 |
3 other studies available for creatine and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Choline; Corpus Striatum; Crea | 2011 |
Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Monophosphate; Animals; Brain; Brain Chemistry; Chromatogr | 2004 |
Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Administration, Oral; Ani | 1999 |